11/06/2024
3:27 PM | NovoCure (Issuer)
Paravasthu Mukund (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/30/2024
6:02 AM | NovoCure (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/30/2024
6:00 AM | NovoCure (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/15/2024
3:05 PM | NovoCure (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/09/2024
5:21 PM | NovoCure (Issuer)
Paravasthu Mukund (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/03/2024
6:00 AM | NovoCure (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2024
3:16 PM | NovoCure (Issuer)
Puri Michal Nath (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
08/06/2024
3:17 PM | Leonard Frank X (Reporting)
NovoCure (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2024
3:19 PM | Cordova Ashley (Reporting)
NovoCure (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2024
3:19 PM | Danziger Asaf (Reporting)
NovoCure (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/25/2024
7:19 AM | NovoCure (Filer)
| Form S-8 POS | |
07/25/2024
7:20 AM | NovoCure (Filer)
| Form S-8 POS | |
07/25/2024
7:21 AM | NovoCure (Filer)
| Form S-8 POS | |
07/25/2024
7:22 AM | NovoCure (Filer)
| Form S-8 POS | |
07/25/2024
7:24 AM | NovoCure (Filer)
| Form S-8 POS | |
07/25/2024
7:25 AM | NovoCure (Filer)
| Form S-8 POS | |
07/25/2024
7:16 AM | NovoCure (Filer)
| Form S-8 POS | |
07/25/2024
7:17 AM | NovoCure (Filer)
| Form S-8 POS | |
07/25/2024
7:18 AM | NovoCure (Filer)
| Form S-8 POS | |
07/25/2024
6:01 AM | NovoCure (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/25/2024
6:05 AM | NovoCure (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/10/2024
12:14 PM | NovoCure (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
07/08/2024
3:32 PM | BlackRock Inc. (Filed by)
NovoCure (Subject)
| Form SC 13G/A | |
06/06/2024
5:37 PM | NovoCure (Issuer)
Ocean Allyson J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2024
5:13 PM | Madden Martin J. (Reporting)
NovoCure (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2024
4:55 PM | Hung David (Reporting)
NovoCure (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2024
4:42 PM | LEUNG GABRIEL (Reporting)
NovoCure (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2024
4:42 PM | NovoCure (Issuer)
Scannell Timothy J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2024
4:43 PM | NovoCure (Issuer)
VERNON W ANTHONY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2024
4:43 PM | NovoCure (Issuer)
Stafford Kristin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2024
4:09 PM | HILLEMAN JERYL L (Reporting)
NovoCure (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2024
7:01 AM | NovoCure (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/02/2024
6:01 AM | NovoCure (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/02/2024
6:01 AM | NovoCure (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
03/27/2024
6:00 AM | NovoCure (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/04/2024
5:39 PM | NovoCure (Subject)
Shah Pritesh (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024
5:17 PM | GROENHUYSEN WILHELMUS CM (Reporting)
NovoCure (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024
3:43 PM | Cordova Ashley (Reporting)
NovoCure (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
3:33 PM | Giladi Moshe (Reporting)
NovoCure (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
3:33 PM | Leupin Nicolas (Reporting)
NovoCure (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
3:35 PM | NovoCure (Issuer)
Weinberg Uri (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
This Bull Market Indicator called NVDA at $116 (Ad) Every now and again we find an investment idea so incredible we can’t help but share.
And today is one of those rare days…
Except, today we won't be giving you insight on any one particular stock…
But rather, insight on a revolutionary new stock picking indicator…
In fact, within the last year, this indicator has become famous for a multitude of reasons…
But one of the biggest was because of the buy signal it issued on October 18th, 2022.
In fact, on that very day, it said to buy NVDA at $116.37…
Anyone who did would be sitting on a tremendously large return today…
But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run… All you have to do is follow this link here |
02/22/2024
6:11 AM | NovoCure (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/22/2024
6:05 AM | NovoCure (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/22/2024
6:06 AM | NovoCure (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/09/2024
8:28 AM | FMR LLC (Filed by)
NovoCure (Subject)
| Form SC 13G/A | |
01/18/2024
6:01 AM | NovoCure (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/12/2024
3:57 PM | Leonard Frank X (Reporting)
NovoCure (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/11/2024
4:15 PM | Leupin Nicolas (Reporting)
NovoCure (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/09/2024
6:00 AM | NovoCure (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2024
6:10 AM | NovoCure (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/04/2024
3:10 PM | NovoCure (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/20/2023
3:23 PM | Giladi Moshe (Reporting)
NovoCure (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/11/2023
5:19 AM | Capital World Investors (Filed by)
NovoCure (Subject)
| Form SC 13G/A | |
11/28/2023
6:30 AM | NovoCure (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
